In 2013, Donald C. “Danny” Danielson established the Danny Danielson Translational Innovation Award, granted by the Walther Cancer Foundation. The award, given twice each year, honored investigators working in partnership with Hoosier Cancer Research Network to support the correlative components of clinical trial protocols when financial support is not otherwise available. The correlatives under investigation must have a future clinical application, such as development of new treatment strategies or identification of patient subsets for specific treatment therapies, and/or provide hypotheses for future clinical trials.
